MyFinsight

HomeBlogAboutContact

MyFinsight

Making company financials insightful for everyone

Quick Links

  • About
  • Blog
  • Contact

Follow Us

  • X.com
  • Thread
  • Instagram

© 2026 MyFinsight. All rights reserved.

|||

For the quarter ending 2025-09-30, KYMR has $1,102,044K in assets. $155,786K in debts. $112,949K in cash and cash equivalents.

Balance Sheets Overview

Current Ratio
738.10%
Cash Ratio
157.81%
Debt to Asset Ratio
14.14%
Assets Breakdown
    • Marketable securities, non-curre...
    • Marketable securities (note 4)
    • Cash and cash equivalents
    • Others
Liabilities Breakdown
    • Additional paid-in capital
    • Accumulated deficit
    • Operating lease liabilities, net...
    • Others

Unit: Thousand (K) dollars (except for numbers of shares and EPS)
Balance Sheets
2025-09-30
2025-06-30
Cash and cash equivalents
112,949 335,816
Marketable securities (note 4)
392,733 329,629
Contract assets
0 0
Accounts receivable
-40,000
Prepaid expenses and other current assets
22,616 22,882
Total current assets
528,298 728,327
Marketable securities, non-current (note 4)
473,055 297,629
Total property and equipment
67,483 -
Less accumulated depreciation
22,355 -
Property and equipment, net (note 6)
45,128 48,572
Right-of-use assets, operating leases
42,947 46,045
Other non-current assets
6,828 4,675
Restricted cash
5,788 5,820
Total assets
1,102,044 1,131,068
Accounts payable
5,506 5,781
Accrued expenses (note 8)
28,639 27,976
Deferred revenue
23,279 40,000
Operating lease liabilities
11,853 11,766
Finance lease liabilities
1,890 1,900
Other current liabilities
408 117
Total current liabilities
71,575 87,540
Deferred revenue, net of current portion
13,957 -
Operating lease liabilities, net of current portion
68,450 69,835
Finance lease liabilities, net of current portion
1,804 2,213
Total liabilities
155,786 159,588
Common stock, 0.0001 par value 150,000,000 shares authorized at september 30, 2025 and december 31, 2024, 71,741,174 and 64,890,193 shares issued and outstanding at september 30, 2025 and december 31, 2024, respectively
7 7
Additional paid-in capital
1,923,730 1,867,999
Accumulated deficit
-978,980 -896,805
Accumulated other comprehensive loss
1,501 279
Total stockholders equity
946,258 971,480
Total liabilities and stockholders equity
1,102,044 1,131,068
Unit: Thousand (K) dollars

Time Plot

Show the time plot by selecting a row from the table.

Balance Sheets

Total property andequipment$67,483K Prepaid expenses andother current assets$22,616K Marketable securities(note 4)$392,733K Cash and cashequivalents$112,949K Restricted cash$5,788K Other non-currentassets$6,828K Right-of-use assets,operating leases$42,947K Property and equipment,net (note 6)$45,128K Marketable securities,non-current (note 4)$473,055K Total current assets$528,298K Less accumulateddepreciation$22,355K Total assets$1,102,044K Total liabilities andstockholders equity$1,102,044K Total stockholdersequity$946,258K Total liabilities$155,786K Accumulated deficit-$978,980K Accumulated othercomprehensive loss$1,501K Additional paid-in capital$1,923,730K Finance leaseliabilities, net of current...$1,804K Operating leaseliabilities, net of current...$68,450K Deferred revenue, net ofcurrent portion$13,957K Total currentliabilities$71,575K Common stock, 0.0001par value...$7K Other currentliabilities$408K Finance leaseliabilities$1,890K Operating leaseliabilities$11,853K Deferred revenue$23,279K Accrued expenses (note8)$28,639K Accounts payable$5,506K

Kymera Therapeutics, Inc. (KYMR)

Kymera Therapeutics, Inc. (KYMR)